WESPAC Advisors SoCal’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

WESPAC Advisors SoCal’s Portfolio NMRD Stock Details NMRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-323	Closed	-$2K	–	366
2018 Q4	$2K	Buy	+323	New	+$5.78K	﹤0.01%	315

Other funds holding NMRD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CFGS

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

WESPAC Advisors SoCal's NMRD Position: Q1 2019 in Review

WESPAC Advisors SoCal sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2019, closing a stake of 323 shares — an estimated $2K sold.

WESPAC Advisors SoCal first reported a position in NMRD in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 5 funds tracked by Wall St. Rank hold NMRD as of Q1 2019.

WESPAC Advisors SoCal reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
WESPAC Advisors SoCal sold 323 Nemaura Medical, Inc. Common Stock shares in Q1 2019, an estimated $2K.
WESPAC Advisors SoCal first reported a position in Nemaura Medical, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
WESPAC Advisors SoCal's Nemaura Medical, Inc. Common Stock position peaked at $2K in Q4 2018.
5 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q1 2019, filed 2 May 2019.